US30231G1022 - Common Stock
2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
---|---|---|---|---|---|---|---|---|---|---|
Revenue YoY % growth | 276.692B 54.95% | 398.675B 44.09% | 334.697B -16.05% | 336.936B 0.67% | N/A | |||||
EBITDA YoY % growth | 46.189B 11.93% | 91.128B 97.29% | 67.888B -25.50% | 76.106B 12.11% | N/A | |||||
EBIT YoY % growth | 25.582B 639.48% | 71.688B 180.23% | 47.247B -34.09% | 53.606B 13.46% | ||||||
Operating Margin | 9.25% | 17.98% | 14.12% | 15.91% | N/A | |||||
EPS YoY % growth | 5.38 1,781.25% | 14.06 161.34% | 9.52 -32.29% | 9.26 -2.76% |
All data in USD
Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS Q2Q % growth | 2.41 23.98% | ||||||||||
Revenue Q2Q % growth | 81.287B 0.61% | ||||||||||
EBITDA Q2Q % growth | 20.064B | ||||||||||
EBIT Q2Q % growth | 13.094B 24.43% |
All data in USD
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 2.06 -27.21% | 2.25 | -0.19 | -8.30% |
Q4 2023 Q2Q % growth | 2.48 -27.06% | 2.24 | 0.24 | 10.91% |
Q3 2023 Q2Q % growth | 2.27 -48.99% | 2.40 | -0.13 | -5.30% |
Q2 2023 Q2Q % growth | 1.94 -53.14% | 2.03 | -0.09 | -4.65% |
Period | Reported | Estimate | Difference | Surprise |
---|---|---|---|---|
Q1 2024 Q2Q % growth | 80.411B -3.87% | 78.739B | 1.672B | 2.12% |
Q4 2023 Q2Q % growth | 81.688B -12.32% | 86.086B | -4.398B | -5.11% |
Q3 2023 Q2Q % growth | 88.57B -16.85% | 89.707B | -1.137B | -1.27% |
Q2 2023 Q2Q % growth | 80.795B -27.39% | 86.761B | -5.966B | -6.88% |
Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
---|---|---|---|---|
EPS | 5.7% | 8.2% | 4.29% | 2.34% |
Revenue | 0.54% | -9.2% | 0.79% | -3.72% |